Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|30|4658-4668

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.30, 2016-09, pp. : 4658-4668

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sex differences in vascular dysfunction and cardiovascular outcomes: The cardiac, endothelial function, and arterial stiffness in ESRD (CERES) study

By  

Hemodialysis International, Vol. 22, Iss. 1, 2018-01 ,pp. : 93-102

John Wiley & Sons Inc

Access to resources Recommend Favorite

Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets

By  

Current Medicinal Chemistry, Vol. 16, Iss. 1, 2009-01 ,pp. : 94-112

Bentham Science Publishers

Access to resources Recommend Favorite

Arterial Stiffness and Cardiovascular Drugs

By  

Current Pharmaceutical Design, Vol. 9, Iss. 13, 2003-05 ,pp. : 1049-1063

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines as Therapeutic Targets to Reduce Cardiovascular Risk in Chronic Inflammation

By  

Current Pharmaceutical Design, Vol. 17, Iss. 1, 2011-01 ,pp. : 1-8

Bentham Science Publishers

Access to resources Recommend Favorite

Tachykinins as Therapeutic Targets in Inflammation

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 2, Iss. 1, 2003-03 ,pp. : 19-27

Bentham Science Publishers

Access to resources Recommend Favorite